
New gene-editing project targets thalassemia’s root cause
A new research project at the Cyprus Institute of Neurology and Genetics (CING) aims to develop a one-time, curative therapy for beta-thalassemia, the most common inherited blood disorder in Cyprus.
The Molecular Genetics Thalassaemia Department (MGTD) of the institute has announced the launch of the BETA-BET: Targeted Base Editing for Beta Thalassemia project, which seeks to advance a personalised gene therapy targeting the






